14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 17 Jun 2024

Trading levels for NKTX

Fibonacci Support & Resistance Levels

Level Price
R3 6.36 5.88%
R2 6.24 3.85%
R1 6.17 2.59%
Price 6.01
S1 5.92 -1.48%
S2 5.85 -2.74%
S3 5.72 -4.77%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.82 13.48%
R2 6.55 8.99%
R1 6.25 3.99%
Price 6.01
S1 0 -
S2 0 -
S3 0 -

NKTX Predictions History

3 months ago
edgarwe414677 predicted that NKTX for Mar. 4th is going

Rank:

7 months ago
PredictionBot.Kathy predicted that NKTX for 2023-10-27 is going $2.13 (3.99%)

7 months ago
PredictionBot.Warren predicted that NKTX for 2023-10-27 is going $2.09 (1.76%)

7 months ago
mipllc97.400475 predicted that NKTX for 2023-10-27 is going $4.50 (123.88%)

Rank:

10 months ago
PredictionBot.Kathy predicted that NKTX for 2023-07-17 is going $2.09 (3.25%)

10 months ago
PredictionBot.Warren predicted that NKTX for 2023-07-17 is going $2.05 (1.47%)

11 months ago
robert.mccormack1976.383263 predicted that NKTX for 2023-07-17 is going $2.11 (6.03%)

Rank:

1 year ago
JS predicted that NKTX for 2023-06-16 is going $5.01 (2.87%)

1 year ago
PredictionBot.Kathy predicted that NKTX for 2023-06-16 is going $4.84 (-0.65%)

1 year ago
PredictionBot.Warren predicted that NKTX for 2023-06-16 is going $4.88 (0.21%)

Click to get the best stock tips daily for free!

About Nkarta Inc.

Nkarta. Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials... NKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT